Genome-editing tools for stem cell biology

Cell Death and Disease

Volumn 6, Issue 7, 2015, Pages

  Vasileva, E A ^a   Shuvalov, O U ^a   Garabadgiu, A V ^b   Melino, G ^b,c   Barlev, N A ^a,b  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

^b Technological University   (Russian Federation)

^c MRC TOXICOLOGY UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CRISPR ASSOCIATED PROTEIN; HISTONE ACETYLTRANSFERASE; NUCLEASE; PROTEIN P53; RNA GUIDED DNA SPECIFIC NUCLEASE; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; BACTERIAL PROTEIN; BIOLOGICAL MARKER; CAS9 PROTEIN, FRANCISELLA NOVICIDA; ENDONUCLEASE; HOMEODOMAIN PROTEIN; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; MYC PROTEIN, HUMAN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; REPRESSOR PROTEIN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

CELL DIFFERENTIATION; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CYTOLOGY; DNA BINDING; GENE EXPRESSION; GENETIC ENGINEERING; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SOMATIC CELL; STEM CELL; TRANSCRIPTION INITIATION; GENETICS; HUMAN GENOME; METABOLISM;

BACTERIAL PROTEINS; BIOMARKERS; CELL DIFFERENTIATION; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; ENDONUCLEASES; GENE EXPRESSION; GENOME, HUMAN; HOMEODOMAIN PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; SOXB1 TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; ZINC FINGERS;

EID: 84947108021     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.167     Document Type: Review

References (89)

1. Thomson JA. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
3. Wei X, Chen Y, Xu Y, Zhan Y., Zhang R, Wang M et al. Small molecule compound induces chromatin de-condensation and facilitates induced pluripotent stem cell generation. J Mol Cell Biol 2014; 6: 409-420.
4. Ma J. Transcriptional activators and activation mechanisms. Protein Cell 2011; 2: 879-888.
5. Huangfu D, Maehr R, Guo W, Eijkelenboom A., Snitow M, Chen AE et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008; 26: 795-797.
6. Chen J, Gao Y, Huang H, Xu K., Chen X, Jiang Y et al. The combination of Tet1 with Oct4 generates high-quality mouse induced pluripotent stem cells (iPSCs). Stem Cell 2014;: 1-16.
7. Lloyd A, Plaisier CL, Carroll D, Drews GN. Targeted mutagenesis using zinc-finger nucleases in Arabidopsis. Proc Natl Acad Sci USA 2005; 102: 2232-2237.
8. Beumer K, Bhattacharyya G, Bibikova M, Trautman J.K., Carroll D. Efficient gene targeting in Drosophila with zinc-finger nucleases. Genetics 2006; 172: 2391-2403.
9. Doyon Y, McCammon JM, Miller JC, Faraji F, Ngo C., Katibah GE et al. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat Biotechnol 2008; 26: 702-708.
10. Carbery ID, Ji D, Harrington A, Brown V., Weinstein EJ, Liaw L et al. Targeted genome modification in mice using zinc-finger nucleases. Genetics 2010; 186: 451-459.
11. Mashimo T, Takizawa A, Voigt B, Yoshimi K., Hiai H, Kuramoto T et al. Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases. PLoS One 2010; 5: e8870.
12. Hauschild J, Petersen B, Santiago Y, Queisser A., Carnwath JW, Lucas-hahn A et al. Correction for Hauschild et al., Efficient generation of a biallelic knockout in pigs using zincfinger nucleases. Proc Natl Acad Sci USA 2011; 108: 15010-15010.
13. Urnov FD, Miller JC, Lee Y-L, Beausejour CM, Rock J.M., Augustus S et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 2005; 435: 646-651.
14. Urnov FD, Rebar EJ, Holmes MC, Zhang H.S., Gregory PD. Genome editing with engineered zinc finger nucleases. Nat Rev Genet 2010; 11: 636-646.
15. Soldner F, Laganière J, Cheng AW, Hockemeyer D, Gao Q., Alagappan R et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 2011; 146: 318-331.
16. Sebastiano V, Maeder ML, Angstman JF, Haddad B, Khayter C., Yeo DT et al. NIH Public Access 2012; 29: 1717-1726.
17. Yusa K, Rashid ST, Strick-marchand H, Varela I, Liu P., Darche S et al. Targeted gene correction of α 1-antitrypsin deficiency in induced pluripotent stem cells. Nature 2012; 478: 391-394.
18. Christian M, Qi Y, Zhang Y, Voytas DF. Targeted mutagenesis of Arabidopsis thaliana using engineered TAL effector nucleases. G3 (Bethesda) 2013; 3: 1697-1705.
19. Katsuyama T, Akmammedov A, Seimiya M, Hess S.C., Sievers C., Paro R. An efficient strategy for TALEN-mediated genome engineering in Drosophila. Nucleic Acid Res 2013; 41: e163.
20. Cheng Z, Yi P, Wang X, Chai Y., Feng G, Yang Y et al. Conditional targeted genome editing using somatically expressed TALENs in C elegans. Nat Biotechnol 2013; 31: 934-937.
21. Cade L, Reyon D, Hwang WY, Tsai S.Q., Patel S., Khayter C et al. Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs. Nucleic Acid Res 2012; 40: 8001-8010.
22. Lei Y, Guo X, Liu Y, Cao Y., Deng Y, Chen X et al. Efficient targeted gene disruption in Xenopus embryos using engineered transcription activator-like effector nucleases (TALENs). Proc Natl Acad Sci USA 2012; 109: 17484-17489.
23. Qiu Z, Liu M, Chen Z, Shao Y., Pan H, Wei G et al. High-efficiency and heritable gene targeting in mouse by transcription activator-like effector nucleases. Nucleic Acid Res 2013; 41: e120.
24. Tesson L, Usal C, Ménoret S, Leung E, Niles B.J., Remy S et al. Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol 2011; 29: 695-696.
25. Song J, Zhong J, Guo X, Chen Y., Zou Q, Huang J et al. Generation of RAG 1-and 2-deficient rabbits by embryo microinjection of TALENs. Cell Res 2013; 23: 1059-1062.
26. Hockemeyer D, Wang H, Kiani S, Lai C.S., Gao Q., Cassady JP et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 2011; 29: 731-734.
27. Holkers M, Maggio I, Liu J, Janssen J.M., Miselli F., Mussolino C et al. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res 2013; 41: e63.
28. Li L, Atef A, Piatek A, Ali Z., Piatek M, Aouida M et al. Characterization and DNA-binding specificities of Ralstonia TAL-like effectors. Mol Plant 2013; 6: 1318-1330.
29. Moscou MJ, Bogdanove AJ. A simple cipher governs DNA recognition by TAL effectors. Science 2009; 326: 1501.
30. Konermann S, Brigham MD, Trevino AE, Hsu P.D., Heidenreich M., Cong L et al. Optical control of mammalian endogenous transcription and epigenetic states. Nature 2013; 500: 472-476.
31. Liu H, Yu X, Li K, Klejnot J., Yang H, Lisiero D et al. Photoexcited CRY2 interacts with CIB1 to regulate transcription and floral initiation in Arabidopsis. Science 2008; 322: 1535-1539.
32. Mendenhall EM, Williamson KE, Reyon D, Zou JY, Ram O, Joung JK et al. Locus-specific editing of histone modifications at endogenous enhancers. Nat Biotechnol 2013; 31: 1133-1136.
33. Makarova KS, Grishin N V, Shabalina SA, Wolf Y.I., Koonin E V. A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct 2006; 1: 7.
34. Jinek M, Chylinski K, Fonfara I, Hauer M., Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012; 337: 816-821.
35. Cho SW, Kim S, Kim JM, Kim J-S. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 2013; 31: 230-232.
36. Deveau H, Barrangou R, Garneau JE, Labonté J, Fremaux C, Boyaval P et al. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol 2008; 190: 1390-1400.
37. Karvelis T, Gasiunas G, Miksys A, Barrangou R., Horvath P, Siksnys V. crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus. RNA Biol 2013; 10: 841-851.
38. Hou Z, Zhang Y, Propson NE, Howden S.E., Chu L-F, Sontheimer EJ et al. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci USA 2013; 110: 15644-9.
39. Jiang W, Zhou H, Bi H, Fromm M., Yang B, Weeks DP. Demonstration of CRISPR/Cas9/sgRNA-mediated targeted gene modification in Arabidopsis, tobacco, sorghum and rice. Nucleic Acid Res 2013; 41: e188.
40. Liu P, Long L, Xiong K, Yu B., Chang N, Xiong J-W et al. Heritable/conditional genome editing in C. elegans using a CRISPR-Cas9 feeding system. Cell Res 2014: 1-4.
41. Bassett AR, Tibbit C, Ponting CP, Liu J-L. Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system. Cell Rep 2013; 4: 220-228.
42. Hwang WY, Fu Y, Reyon D, Maeder M.L., Tsai SQ, Sander JD et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 2013; 31: 227-229.
43. Ota S, Hisano Y, Ikawa Y, Kawahara A. Multiple genome modifications by the CRISPR/Cas9 system in zebrafish. Gene Cell 2014: 1-10.
44. Shen B, Zhang J, Wu H, Wang J., Ma K, Li Z et al. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res 2013; 23: 720-723.
45. Li D, Qiu Z, Shao Y, Chen Y., Guan Y, Liu M et al. Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat Biotechnol 2013; 31: 681-683.
46. González F., Zhu Z, Shi Z-D, Lelli K, Verma N., Li QV et al. An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells. Cell Stem Cell 2014: 1-12.
47. Kearns N.a., Genga RMJ, Enuameh MS, Garber M, Wolfe S a, Maehr R. Cas9 effectormediated regulation of transcription and differentiation in human pluripotent stem cells. Development 2014; 141: 219-223.
48. Young I.Y., Hae-Sook Ha. Structure, expression and chromosomal location of the Oct-4 gene. Mech Dev 1991; 35: 171-179.
49. Nichols J, Zevnik B, Anastassiadis K, Niwa H., Klewe-nebenius D, Chambers I et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998; 95: 379-391.
50. Niwa H. Molecular mechanism to maintain stem cell renewal of ES cells exogenous signal to maintain ES self-renewal signal transduction of LIF LIF-independent signal. ESRF 2001; 148: 137-148.
51. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES. cells 2000; 24: 2-6.
52. Maurizio P, Hans S. Oct-4 control of totipotency and germline. Mol Reprod Dev 2000; 457: 452-457.
53. Yeom Y, II, Fuhrmann G, Ovitt CE, Brehm A, Ohbo K, Gross M et al. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal. cells 1996: 881-94.
54. Nordhoff V, Hübner K, Bauer A, Orlova I., Malapetsa A, Schöler HR. Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences. Mamm Genome 2001; 12: 309-317.
55. Wang J, Rao S, Chu J, Shen X., Levasseur DN, Theunissen TW et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006; 444: 364-368.
56. Pardo M, Lang B, Yu L, Prosser H., Bradley A, Babu MM et al. An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 2010; 6: 382-395.
57. Gu P, Xu X, Le Menuet D, AC-K Chung, Cooney AJ. Differential recruitment of methyl CpG-binding domain factors and DNA methyltransferases by the orphan receptor germ cell nuclear factor initiates the repression and silencing of Oct4. Stem Cells 2011; 29: 1041-1051.
58. Yang Y, Wang Y, Yin C, Li X. Clinical significance of the stem cell gene Oct-4 in cervical cancer. Tumour Biol 2014; 35: 5339-5345.
59. Beltran AS, Rivenbark AG, Richardson BT, Yuan X, Quian H., Hunt JP et al. Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor. Breast Cancer Res 2011; 13: R94.
60. Peng S, Maihle NJ, Huang Y. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 2010; 29: 2153-2159.
61. Baetsevih V.V. Engineered zinc finger proteins for controlling. Stem Cell Fate 2003: 632-637.
62. Iyengar S, Farnham PJ. KAP1 protein: an enigmatic master regulator of the genome. J Biol Chem 2011; 286: 26267-26276.
63. Iyengar S, Ivanov A V, Jin VX, Rauscher F.J., Farnham PJ. Functional analysis of KAP1 genomic recruitment. Mol Cell Biol 2011; 31: 1833-1847.
64. Stolzenburg S, Rots MG, Beltran AS, Rivenbark A.G., Yuan X., Qian H et al. Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer. Nucleic Acid Res 2012; 40: 6725-6740.
65. Frietze S, Lan X, Jin VX, Farnham PJ. Genomic targets of the KRAB and SCAN domain-containing zinc finger protein 263. J Biol Chem 2010; 285: 1393-1403.
66. Juárez-Moreno K., Erices R, Beltran AS, Stolzenburg S, Cuello-Fredes M, Owen GI et al. Breaking through an epigenetic wall: re-activation of Oct4 by KRAB-containing designer zinc finger transcription factors. Epigenetics 2013; 8: 164-176.
67. Collins T, Stone JR, Williams AJ, Williams AMYJ. SCAN. Domains MINIREVIEW All in the Family: the BTB/POZ, KRAB, and SCAN Domains. Mol Cell Biol 2001; 21: 3609-3615.
68. Schultz DC, Ayyanathan K, Negorev D, Maul G.G., Rauscher FJ. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Gene Dev 2002; 16: 919-932.
69. Ji Q, Fischer AL, Brown CR, Eastlund E.R., Dvash T., Zhong B et al. Engineered zinc-finger transcription factors activate OCT4 (POU5F1), SOX2, KLF4, c-MYC (MYC) and miR302/367. Nucleic Acid Res 2014; 42: 6158-6167.
70. Zhang F, Cong L, Lodato S, Kosuri S., Church GM, Arlotta P. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 2011; 29: 149-154.
71. Bultmann S, Morbitzer R, Schmidt CS, Thanisch K, Spada F., Elsaesser J et al. Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acid Res 2012; 40: 5368-5377.
72. Gao X, Yang J, Tsang JCH, Ooi J, Wu D., Liu P. Reprogramming to pluripotency using designer TALE transcription factors targeting enhancers. Stem Cell Rep 2013; 1: 183-197.
73. Hu J, Lei Y, Wong W-K, Liu S, Lee K-C, He X et al. Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors. Nucleic Acid Res 2014; 42: 4375-4390.
74. Qi LS, Larson MH, Gilbert L a, Doudna J a, Weissman JS, Arkin AP et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 2013; 152: 1173-1183.
75. Gilbert L.a., Larson MH, Morsut L, Liu Z, Brar G a, Torres SE et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 2013; 154: 442-451.
76. Cheng AW, Wang H, Yang H, Shi L., Katz Y, Theunissen TW et al. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res 2013; 23: 1163-1171.
77. Gao X, Tsang JCH, Gaba F, Wu D., Lu L, Liu P. Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers. Nucleic Acid Res 2014; 14: e155.
78. Hilton IB, D'Ippolito AM, Vockley CM, Thakore PI, Crawford G.E., Reddy TE et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol 2015; 33: 510-517.
79. Gore A, Li Z, Fung H-L, Young JE, Agarwal S, Antosiewicz-Bourget J et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011; 471: 63-67.
80. Pasi CE, Dereli-Öz A, Negrini S, Friedli M, Fragola G, Lombardo A et al. Genomic instability in induced stem cells. Cell Death Differ 2011; 18: 745-753.
81. Phesse TJ, Myant KB, Cole AM, Ridgway R.A., Pearson H., Muncan V et al. Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo. Cell Death Differ 2014; 21: 956-966.
82. Rufini A, Tucci P, Celardo I, Melino G. Senescence and aging: the critical roles of p53. Oncogene 2013; 32: 5129-5143.
83. Antonov AV, Krestyaninova M, Knight RA, Rodchenkov I, Melino G., Barlev NA. PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome. Oncogene 2014; 33: 1621-1628.
84. Marouco D, Garabadgiu A V, Melino G, Barlev NA. Lysine-specific modifications of p53: a matter of life and death? Oncotarget 2013; 4: 1556-1571.
85. Lezina L, Aksenova V, Ivanova T, Purmessur N., Antonov a V, Tentler D et al. KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress. Cell Death Differ 2014; 21: 1889-1899.
86. Marión R.M., Strati K, Li H, Murga M., Blanco R, Ortega S et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009; 460: 1149-1153.
87. Ichida JK, Tcw J, TCW J, Williams LA, Carter AC, Shi Y et al. Notch inhibition allows oncogene-independent generation of iPS cells. Nat Chem Biol 2014; 10: 632-639.
88. Chen C-Y, Liao W., Lou Y-L, Li Q, Hu B., Wang Y et al. Inhibition of Notch signaling facilitates the differentiation of human-induced pluripotent stem cells into neural stem cells. Mol Cell Biochem 2014; 395: 291-298.
89. Li Y, Feng H, Gu H, Lewis D.W., Yuan Y., Zhang L et al. The p53-PUMA axis suppresses iPSC generation. Nat Commun 2013; 4: 2174.